Jeff Evanson's most recent trade in Outlook Therapeutics Inc was a trade of 25,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Outlook Therapeutics Inc | Jeff Evanson | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Jeff Evanson | CHIEF COMMERCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 0.42 per share. | 07 Mar 2024 | 62,484 | 808,459 (1%) | 0% | 0.4 | 26,243 | Common Stock |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 192,143 | 192,143 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.11 per share. | 20 Jan 2023 | 267,000 | 745,975 (1%) | 0% | 1.1 | 296,370 | Common Stock |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.22 per share. | 17 Jan 2023 | 103,255 | 1,012,975 (1%) | 0% | 1.2 | 125,971 | Common Stock |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.25 per share. | 17 Jan 2023 | 33,738 | 1,116,230 (2%) | 0% | 1.3 | 42,173 | Common Stock |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.31 per share. | 17 Jan 2023 | 27,162 | 1,149,968 (2%) | 0% | 1.3 | 35,582 | Common Stock |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2021 | 800,000 | 800,000 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 1.34 per share. | 03 Dec 2021 | 35,200 | 1,177,130 (2%) | 0% | 1.3 | 47,168 | Common Stock |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.09 per share. | 23 Feb 2021 | 8,554 | 1,141,930 (2%) | 0% | 2.1 | 17,861 | Common Stock |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 12 Feb 2021 | 56,973 | 1,150,484 (2%) | 0% | 2.5 | 145,281 | Common Stock |